Effects of polymorphisms in ABCG2, SLCO1B1, SLC10A1 and CYP2C9/19 on plasma concentrations of rosuvastatin and lipid response in Chinese patients

Pharmacogenomics , August 2013, Vol. 14, No. 11, Pages 1283-1294.
Source: Future Medicine: Pharmacogenomics - Category: Genetics & Stem Cells Tags: article Source Type: research